Diet, Exercise and Vitamin D in Breast Cancer Recurrence

NCT02786875 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 506

Last updated 2022-05-23

No results posted yet for this study

Summary

The purpose of this study is to reduce breast cancer recurrence and hence increase disease-free survival through a lifestyle program that includes a low glycemic diet, physical activity and vitamin D supplementation in women with breast cancer living in a Mediterranean country.

Conditions

Interventions

OTHER

low Glycemic Index Mediterranean diet

All carbohydrate foods will be low GI choices (GI\<70 on bread scale, e.g. legumes, pasta al dente, barley, oat, apples, oranges, berries, nuts) within a healthy Mediterranean diet (≥5 servings veg/fruit per day, ≤1 serving red meat+cold cuts/week, \<7% SFA).

OTHER

Mediterranean diet

General recommendations for a healthy Mediterranean diet (≥5 servings veg/fruit per day, ≤1 serving red meat+cold cuts/week, \<7% SFA).

BEHAVIORAL

Moderate physical activity

Brisk walk of at least 30min per day (or approximately 5000 steps) more than the habitual physical activity.

BEHAVIORAL

Basic physical activity

General recommendations for physical activity

DRUG

high level Vitamin D

Vitamin D supplement (cholecalciferol) up to 4000 IU/day to reach normal blood levels of 60-80 ng/ml of 25(OH)D.

DRUG

normal level Vitamin D

Vitamin D (cholecalciferol) will be given only if vitamin D insufficiency is detected to bring blood levels up to normal ranges of 30ng/mL.

Sponsors & Collaborators

  • Unity Health Toronto

    collaborator OTHER
  • University of Catania

    collaborator OTHER
  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Egidio Celentano, M.D. · National Cancer Institute IRCCS Pascale Naples (Italy)

  • Livia S Augustin, PhD · National Cancer Institute IRCCS Pascale Naples (Italy)

  • Massimo Libra, M.D. · University of Catania, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-04
Primary Completion
2020-10-10
Completion
2023-12-15

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786875 on ClinicalTrials.gov